Koss-Olinger Consulting’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,539
| Closed | -$230K | – | 171 |
|
|
2023
Q4 | $230K | Sell |
4,539
-13,368
| -75% | -$677K | 0.02% | 279 |
|
|
2023
Q3 | $812K | Hold |
17,907
| – | – | 0.12% | 97 |
|
|
2023
Q2 | $735K | Sell |
17,907
-361
| -2% | -$14.8K | 0.09% | 113 |
|
|
2023
Q1 | $653K | Sell |
18,268
-295
| -2% | -$10.5K | 0.08% | 114 |
|
|
2022
Q4 | $701K | Sell |
18,563
-17,376
| -48% | -$656K | 0.1% | 100 |
|
|
2022
Q3 | $1.59M | Sell |
35,939
-2,983
| -8% | -$132K | 0.27% | 29 |
|
|
2022
Q2 | $1.44M | Sell |
38,922
-5,198
| -12% | -$192K | 0.26% | 31 |
|
|
2022
Q1 | $1.63M | Buy |
44,120
+14,959
| +51% | +$554K | 0.26% | 32 |
|
|
2021
Q4 | $887K | Buy |
29,161
+17,729
| +155% | +$539K | 0.14% | 61 |
|
|
2021
Q3 | $383K | Buy |
+11,432
| New | +$383K | 0.06% | 145 |
|